JG-2016
JG-2016 is a potent inhibitor of histone acetyltransferase 1 (HAT1) with an IC50 of 14.8 μM. JG-2016 can inhibit the growth of multiple tumor cells and has anti-tumor activity[1].
Product Specifications
CAS Number
[2887480-87-5]
UNSPSC
12352005
Target
Histone Acetyltransferase
Type
Reference compound
Related Pathways
Epigenetics
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/jg-2016.html
Purity
98.44
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(N1)N=C2N(CCOCC(C)C)C3=CC(CC)=C(Cl)C=C3N=C2C1=O
Molecular Formula
C18H21ClN4O3
Molecular Weight
376.84
References & Citations
[1]Joshua James GRUBER, et al. Modulators of histone acetyltransferase 1 and methods of treatment thereof. Patent, WO2022272313A1.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6352403-01 0.2 mL
STXBP2, CT (STXBP2, UNC18B, Syntaxin-binding protein 2, Protein unc-18 homolog 2, Protein unc-18 homolog B) (Biotin)
Ask
View Details 
MBS6352403-02 5x 0.2 mL
STXBP2, CT (STXBP2, UNC18B, Syntaxin-binding protein 2, Protein unc-18 homolog 2, Protein unc-18 homolog B) (Biotin)
Ask
View Details 037803-ML750 100 µL
LIN7B, NT (LIN7B, MALS2, VELI2, Protein lin-7 homolog B, Mammalian lin-seven protein 2, Vertebrate lin-7 homolog 2) (MaxLight 750) discontinued
Ask
View Details